MS-104: Optimizing MS Treatment: Case Studies and Applications in Specialty Pharmacy Practice (A CSPE Core Curriculum Series)

As the final installment in the four-module NASP/CSPE MS Core Curriculum Series, this capstone activity of the MS curriculum uses case studies to allow participants to apply what was learned in modules MS-101 through MS-103.

Multiple Sclerosis: Optimizing Adverse Effect Management with Disease-Modifying Therapy

This is a featured CE activity on the Center for Specialty Pharmacy Education (CSPE) website. CSPE is the educational hub of the National Association of Specialty Pharmacy (NASP). This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Nutrition in Cancer Care

Nutrition therapy is an important part of managing oncology patient’s adverse effects and hopefully by managing these issues it will increase the patient’s quality of life. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Opioid Stewardship: Opioid Abuse, Naloxone Administration, and Guidance for U.S. Pharmacists in Drug Overdose Emergencies

This activity is designed to provide continuing education to pharmacists who may dispense naloxone via a standing order or similar protocols allowed by their respective states.

Optimization of IVIG and SCIG: Patient Centered Care and the Role of Specialty Pharmacies

This activity will focus on primary immune deficiency along with practicalities and pitfalls when prescribing therapies for these patients. Optimizing therapy and the role of the specialty pharmacist will also be discussed. Available for free to NASP members. Visit www.ProCE.com/CSPE

Optimizing Hepatitis C Disease Management: Implications for Specialty Pharmacy

This CE activity will present strategies to support treatment adherence, navigate cost issues, manage special populations, and ensure optimal patient outcomes.

Outsmarting Multi-Drug Resistance in Uncertain Times

Participants will gain knowledge of current antibiotic resistance trends and infections. Antimicrobial agents will be discussed, with a focus on current limitations and new therapeutic agents on the horizon.

Ovarian Cancer: Implications for the Pharmacist

This session will cover the mechanism of action of the PARP inhibitors and the efficacy and safety parameters of the ovarian cancer treatment options available. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Pharmacy Transplant Series: Managing Infectious Complications with a Focus on CMV

The Pharmacy Transplant Series is designed to help pharmacists better understand the very complicated post-transplant immunosuppressive regimens, the basics of immunosuppression and the issues related to infections during the post-transplant period.

Pharmacy Transplant Series: The Basics of Maintenance Immunosuppression

The Pharmacy Transplant Series is designed to help pharmacists better understand the very complicated post-transplant immunosuppressive regimens, the basics of immunosuppression and the issues related to infections during the post-transplant period.